Cidara Therapeutics, Inc. — Director's Dealing 2021

Jul 31, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Cidara Therapeutics, Inc. (CDTX)
CIK: 0001610618
Period of Report: 2021-07-30

Reporting Person: Johnson Brady (Vice President, Finance)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-07-30	Stock Option (right to buy)	$1.52	A	20000	Acquired	2031-07-29	Common Stock (20000.0)	Direct

Footnotes

F1: The option shall vest and become exercisable in a series of thirty-six (36) successive equal monthly installments measured from the Vesting Commencement Date of July 9, 2021.